Injectable Tirzepatide is a cutting-edge, once-weekly weight loss and metabolic health medication designed for adults with obesity or overweight conditions, especially those with related issues like insulin resistance or type 2 diabetes. It is the first dual-action GLP-1 and GIP receptor agonist, offering a powerful combination that enhances both appetite regulation and metabolic function.
Tirzepatide mimics two natural gut hormones (GLP-1 and GIP) to lower appetite, slow gastric emptying, and improve insulin sensitivity—leading to significant weight loss, better blood sugar control, and enhanced energy. In clinical trials, tirzepatide has shown greater weight reduction compared to single-pathway treatments, making it one of the most advanced tools available in modern weight management.
At Precision Health, injectable tirzepatide is compounded to meet high standards and prescribed through a streamlined telehealth process. Patients receive expert guidance, lab-based dosing plans, and ongoing support—all with discreet home delivery and flexible treatment plans.
Key Benefits:
Common Dosage: Starts at 2.5 mg/week and gradually increases (up to 15 mg, as tolerated)
Form: Pre-filled syringe or vial (compounded)
Route: Subcutaneous injection
Prescription Required: Yes
Monitoring: Routine check-ins and lab work are recommended for optimal results and safety